Literature DB >> 10522992

Diagnostic value of fluorometric assays in the evaluation of precocious puberty.

V N Brito1, M C Batista, M F Borges, A C Latronico, M B Kohek, A C Thirone, B H Jorge, I J Arnhold, B B Mendonca.   

Abstract

To establish normative data and determine the value of fluorometric AutoDELFIA assays (Wallac Oy) in the investigation of precocious puberty, we determined serum levels of LH, FSH, testosterone, and estradiol under basal and GnRH-stimulated conditions in 277 normal subjects at various pubertal stages and in 77 patients with precocious puberty. A substantial overlap was observed in basal and GnRH-stimulated gonadotropin levels in normal individuals of both sexes with pubertal Tanner stages 1 and 2. The 95th percentile of the normal prepubertal population was the cut-off limit between prepubertal and pubertal levels. These limits were 0.6 IU/L in both sexes for basal LH, 9.6 IU/L in boys and 6.9 IU/L in girls for peak LH after GnRH stimulation, 19 ng/dL in boys for basal testosterone, and 13.6 pg/mL in girls for basal estradiol. Basal and peak LH exceeding these limits were considered positive tests for the diagnosis of gonadotropin-dependent precocious puberty. According to these criteria, the sensitivities of basal and peak LH for the latter diagnosis were 71.4% and 100% in boys, and 62.7% and 92.2% in girls. The specificity and positive predicted value were 100% in both sexes for basal and peak LH levels. The negative predicted values for basal and peak LH were 62.5% and 100% in boys, and 40.6% and 76.5% in girls. Basal and GnRH-stimulated FSH levels overlapped among the various pubertal stages in normal subjects and were, in general, not helpful in the differential diagnosis of precocious puberty. In conclusion, basal LH levels were sufficient to establish the diagnosis of gonadotropin-dependent precocious puberty in 71.4% of boys and 62.7% of girls. In the remaining patients, a GnRH stimulation test was still necessary to confirm this diagnosis. Finally, suppressed LH and FSH levels after GnRH stimulation indicate gonadotropin-independent sexual steroid production.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10522992     DOI: 10.1210/jcem.84.10.6024

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  31 in total

1.  Precocious Puberty, GnRH Stimulation Test and Monitoring GnRH Analog Therapy.

Authors:  P S N Menon
Journal:  Indian J Pediatr       Date:  2015-09-18       Impact factor: 1.967

2.  Utility of single luteinizing hormone determination 3 h after depot leuprolide in monitoring therapy of gonadotropin-dependent precocious puberty.

Authors:  Shrikrishna V Acharya; Raju A Gopal; Joe George; Tushar R Bandgar; Padma S Menon; Nalini S Shah
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

3.  Independent relationship between body mass index and LH peak value of GnRH stimulation test in ICPP girls: A cross-sectional study.

Authors:  Yue Zhao; Ling Hou; Hong-Jie Gao; Di Zhan; Cai Zhang; Xiao-Ping Luo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

Review 4.  Diagnosis and management of precocious sexual maturation: an updated review.

Authors:  Amanda Veiga Cheuiche; Leticia Guimarães da Silveira; Leila Cristina Pedroso de Paula; Iara Regina Siqueira Lucena; Sandra Pinho Silveiro
Journal:  Eur J Pediatr       Date:  2021-03-21       Impact factor: 3.183

5.  Left ventricular diastolic dysfunction by tissue Doppler echocardiography in pediatric chronic kidney disease.

Authors:  Ylva Tranæus Lindblad; Jonas Axelsson; Rita Balzano; Georgios Vavilis; Milan Chromek; Gianni Celsi; Peter Bárány
Journal:  Pediatr Nephrol       Date:  2013-06-06       Impact factor: 3.714

Review 6.  Central precocious puberty: current treatment options.

Authors:  Franco Antoniazzi; Giorgio Zamboni
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Comparison of detection of normal puberty in girls by a hormonal sleep test and a gonadotropin-releasing hormone agonist test.

Authors:  Robert L Rosenfield; Brian Bordini; Christine Yu
Journal:  J Clin Endocrinol Metab       Date:  2013-03-01       Impact factor: 5.958

8.  A GPR54-activating mutation in a patient with central precocious puberty.

Authors:  Milena Gurgel Teles; Suzy D C Bianco; Vinicius Nahime Brito; Ericka B Trarbach; Wendy Kuohung; Shuyun Xu; Stephanie B Seminara; Berenice B Mendonca; Ursula B Kaiser; Ana Claudia Latronico
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

9.  Bone mineral density and body composition in male children with hypogonadism.

Authors:  D Fintini; A Grossi; C Brufani; R Fiori; G Ubertini; L Pecorelli; M Cappa
Journal:  J Endocrinol Invest       Date:  2009-06-15       Impact factor: 4.256

10.  Macronutrient intakes and cardio metabolic risk factors in high BMI African American children.

Authors:  Sushma Sharma; Lindsay S Roberts; Mark L Hudes; Robert H Lustig; Sharon E Fleming
Journal:  Nutr Metab (Lond)       Date:  2009-10-13       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.